Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Market Commentary

S&P 500 Retreats from Record High as Jobs Data Sparks Volatility

Robert Sasse by Robert Sasse
September 8, 2025
in Market Commentary, S&P 500, Trading & Momentum
0
S&P 500 Stock
0
SHARES
209
VIEWS
Share on FacebookShare on Twitter

The S&P 500 concluded Friday’s session in negative territory, relinquishing early gains that had propelled the benchmark index to a fresh all-time peak of 6,533 points. The index finished at 6,481.50, marking a daily decline of 20.58 points. This pullback represented a wave of profit-taking that emerged directly at the moment of the bulls’ greatest triumph.

Economic Data Pressures Fed Policy Outlook

Market volatility was primarily triggered by the latest US employment report, which revealed a weaker-than-anticipated labor market. The unemployment rate climbed to 4.3%, significantly exceeding forecasts. This development immediately fueled market speculation, with bets increasing for a potential 50-basis-point interest rate cut by the Federal Reserve at its September 17th meeting.

Bond markets reacted swiftly to the shifting expectations. The yield on the 10-year US Treasury note fell to 4.08%, its lowest level since April. Meanwhile, gold prices advanced to $3,639.80 per ounce, while oil held steady at $61.97 a barrel.

Mixed Performance Among Individual Stocks

Beneath the index’s movement, individual companies experienced dramatic swings. Broadcom surged by 9.4% following an exceptional quarterly report and the announcement of a $10 billion customer, widely believed to be OpenAI. Pool Corp. also posted gains, advancing 5.5% as investors bet on potential interest rate reductions.

However, the session brought substantial losses for others. Lululemon shares plummeted 18.6% after the company released disappointing sales figures and revised its guidance downward. Advanced Micro Devices (AMD) declined 6.6% following a analyst downgrade that cited concerns over waning demand for artificial intelligence products.

Should investors sell immediately? Or is it worth buying S&P 500?

Technical Perspective Remains Constructive

Despite the daily setback, the broader technical outlook for the S&P 500 remains decidedly bullish. The index continues to trade well above its key moving averages:
– 50-day moving average: 6,349.55 points
– 100-day moving average: 6,064.38 points
– 200-day moving average: 5,969.10 points

Technical analysts identify critical support at the 6,400-point level. A sustained hold above this threshold would keep upward prospects intact. The Relative Strength Index (RSI) reading of 58.3% indicates healthy momentum conditions without signaling overbought territory.

Institutional Flows Signal Underlying Confidence

Despite the pullback, institutional investment flows continued to demonstrate market confidence. The SPY ETF recorded substantial inflows of $4.4 billion, while the IVV ETF attracted $1.1 billion. Options traders exhibited more caution, however, with a put/call ratio of 1.15 indicating mild skepticism in the market.

The central question for traders is whether this retreat represents a healthy consolidation after a record-breaking run or the beginning of a more significant correction. The upcoming trading sessions around the 6,400-point marker are expected to provide crucial directional signals for the market’s near-term trajectory.

Ad

S&P 500 Stock: Buy or Sell?! New S&P 500 Analysis from March 25 delivers the answer:

The latest S&P 500 figures speak for themselves: Urgent action needed for S&P 500 investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

S&P 500: Buy or sell? Read more here...

Tags: S&P 500
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Technology Select Sector SPDR® Fund Stock
AI & Quantum Computing

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026
Ocugen Stock
Analysis

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026
Coinbase Stock
Analysis

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

March 25, 2026
Next Post
Airbnb Stock

Navigating Regulatory Headwinds: Airbnb's AI Ambitions Face Policy Challenges

Incyte Stock

Institutional Buying and Insider Selling: The Incyte Investment Conundrum

Mastercard Stock

Mastercard CFO Takes Center Stage at Key Investor Conference

Recommended

iRadimed Stock

iRadimed: Record Performance Meets Divergent Institutional Strategies

7 months ago
Alphabet Stock

Alphabet Shares Under Scrutiny as CEO Pichai Executes Multi-Million Dollar Stock Sale

6 months ago
Bloom Energy Stock

Bloom Energy Shares Plunge Following Spectacular Rally

4 months ago
Strategy Stock

Strategy Shares Plunge Following Dual Capital Raise Announcement

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

Trending

Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

by SiterGedge
March 25, 2026
0

As Humacyte prepares to release its full-year 2025 financial results, the biotechnology firm finds its stock trading...

Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline
  • MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com